Clinical Trials Logo

Filter by:
NCT ID: NCT01559116 Completed - Clinical trials for Pulmonary Disease, Chronic Obstructive

Characterization of 24-hour Lung Function Profiles of Inhaled Tiotropium + Olodaterol Fixed Dose Combination in Patients Suffering From Chronic Obstructive Pulmonary Disease

Start date: March 2012
Phase: Phase 3
Study type: Interventional

The primary objective of the trial is to determine the 24-hour FEV1-time profile of tiotropium + olodaterol FDC, administered once daily by the RESPIMAT Inhaler after 6 weeks of treatment.

NCT ID: NCT01559064 Completed - Clinical trials for Age-related Volume Deficit in the Mid-face

The Volumizing Effect of Juvéderm VOLUMA® in the Mid-Face

Start date: February 2012
Phase: N/A
Study type: Observational

This is a prospective, observational study of the volumizing effect of aesthetic use of Juvéderm VOLUMA® with lidocaine in the mid-face area.

NCT ID: NCT01557829 Completed - Clinical trials for Degenerative Spondylolisthesis

Valeo OL Interbody Fusion Devices for Posterior Lumbar Interbody Fusion SNAP Trial

SNAP
Start date: February 2012
Phase: N/A
Study type: Interventional

This study randomizes degenerative spondylolisthesis and/or degenerative disc patients into two groups: one to receive a new ceramic implant and a control group with a more traditional PEEK plastic implant. The procedure uses a single oblique cage in each group. The study will measure and compare pain and disability improvement with the two implanted devices over a period of two years. The fusion status will also be judged with plane x-rays and one CT scan.

NCT ID: NCT01556737 Completed - Postmenopause Clinical Trials

Effect of Two Different Isoflavone Supplement Preparations on Gene-expression in Postmenopausal Women

ISOII
Start date: November 2011
Phase: N/A
Study type: Interventional

Alleged benefits experienced after the consumption of soy in Asian countries have been attributed to the isoflavone content of soy products. Amongst other benefits, isoflavones are believed to relieve menopausal symptoms and are therefore often consumed in supplement form in Western countries. These supplements contain relatively high amounts of isoflavones and are on the market in different compositions. The question is whether supplements with different compositions exert similar effects or whether the effects differ substantially.

NCT ID: NCT01556490 Completed - Clinical trials for Unresectable Hepatocellular Carcinoma

Efficacy Evaluation of TheraSphere in Patients With Inoperable Liver Cancer

STOP-HCC
Start date: March 2012
Phase: N/A
Study type: Interventional

The safety and effectiveness of TheraSphere will be evaluated in patients with unresectable hepatocellular carcinoma in whom treatment with standard-of-care sorafenib is planned. All patients receive the standard-of-care sorafenib with or without the addition of TheraSphere.

NCT ID: NCT01556321 Completed - Obesity Clinical Trials

Long-term Effects of Green Tea on Gut Flora, Fat Absorption, Body Composition and Resting Energy Expenditure

Start date: June 2012
Phase: N/A
Study type: Interventional

Green tea may have positive effects for weight control and on body composition via several approaches such as a positive effect on the gut flora, a decrease in fat absorption from the intestines and an increase in resting energy expenditure.

NCT ID: NCT01556126 Completed - Clinical trials for Acute Myocardial Infarction

Clinical Performance of CRE8 Drug Eluting Stent in All Comer Population

PARTICIPATE
Start date: February 2012
Phase: N/A
Study type: Interventional

The aim of this study is to evaluate safety and efficacy performances of CRE8 Drug Eluting Stent, in patients comparable to the everyday's clinical practice population, with a specific focus on diabetics, that will be part of a pre-specified study subgroup.

NCT ID: NCT01555294 Completed - Clinical trials for Cardiovascular Disease

Evaluation of Non-invasive Measurements of Atherosclerosis in Cardiovascular Risk Stratification

NIMA
Start date: May 2005
Phase: N/A
Study type: Observational

Multiple risk factors contribute to atherosclerosis, which ultimately results in clinical manifestation of cardiovascular disease. Atherosclerosis results in both functional and morphological changes in the vessel wall, which can be measured by ultrasonography. The current study has been designed to 1. To evaluate whether non-invasive measurements of atherosclerosis are independent predictors of cardiovascular disease and 2. to delineate new biochemical parameters and genetic variations, allowing earlier and more effective preventive therapy 3. The investigators intend to set guidelines for use of NIMA in an outpatient setting to facilitate early detection of increased cardiovascular risk and monitor life-style and pharmaceutical interventions. In both the general population and in Familial Combined Hyperlipidemia.

NCT ID: NCT01555151 Completed - Asthma Clinical Trials

Safety and Efficacy of Mometasone Furoate Delivered Via Concept1 Device or Twisthaler® Device in Adult and Adolescent Patients With Persistent Asthma

Start date: July 2012
Phase: Phase 2
Study type: Interventional

The purpose of this study is to compare the efficacy, safety and pharmacokinetics of Mometasone furoate delivered via Concept1 device or Twisthaler® device in adult and adolescent patients with persistent asthma.

NCT ID: NCT01555138 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease

Comparison of Indacaterol 150 mcg Once Daily (o.d.) With Salmeterol/Fluticasone Propionate 50 mcg/500 mcg Twice Daily (b.i.d.)

INSTEAD
Start date: February 2012
Phase: Phase 4
Study type: Interventional

The purpose of this study is to compare the effectiveness and safety of indacaterol with salmeterol /fluticasone propionate treatment in patients with moderate chronic obstructive pulmonary disease who, on entry to the study are being treated with salmeterol /fluticasone propionate.